title: Neuropeptides and neuronal survival: neuroprotective strategy for Alzheimer's disease.
authors.affiliation: Department of Clinical Biochemistry, Sackler School of Medicine, Tel Aviv University, Israel.
authors.forename: I
authors.initials: I
authors.lastname: Gozes
authors.forename: A
authors.initials: A
authors.lastname: Bardea
authors.forename: M
authors.initials: M
authors.lastname: Bechar
authors.forename: O
authors.initials: O
authors.lastname: Pearl
authors.forename: A
authors.initials: A
authors.lastname: Reshef
authors.forename: R
authors.initials: R
authors.lastname: Zamostiano
authors.forename: A
authors.initials: A
authors.lastname: Davidson
authors.forename: S
authors.initials: S
authors.lastname: Rubinraut
authors.forename: E
authors.initials: E
authors.lastname: Giladi
authors.forename: M
authors.initials: M
authors.lastname: Fridkin
authors.forename: D E
authors.initials: DE
authors.lastname: Brenneman
mesh_terms: D000281:Administration, Intranasal; D000544:Alzheimer Disease / Q000188:drug therapy / Q000473:pathology / Q000517:prevention & control*; D000818:Animals; D016923:Cell Death / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007858:Learning / Q000187:drug effects; D008568:Memory / Q000187:drug effects; D009474:Neurons / Q000187:drug effects* / Q000473:pathology; D009479:Neuropeptides / Q000494:pharmacology* / Q000502:physiology*; D051381:Rats; D014660:Vasoactive Intestinal Peptide / Q000008:administration & dosage / Q000494:pharmacology / Q000502:physiology
chemical_list: D009479:Neuropeptides; C086770:stearyl-norleucine(17)-vasoactive intestinal peptide; D014660:Vasoactive Intestinal Peptide